Akorn Inc Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

A sample of Akorn Inc Insights data

Headline Published Journalists
Showing 2 of 2 results. Subscribe to unlock more.
Deserunt mollit sunt Lorem laborum do id aliqua dolore 22 Sep 2017 Lorem
Allergan/Mohawk deal may open possibility for alternative patent-challenge routes but SCOTUS case may throw IPR issue into question – lawyers 22 Sep 2017 Alaric DeArment
Allergan's efforts to dismiss IPR through Mohawk patent deal hinge on extent of sovereign immunity – experts 21 Sep 2017 Alaric DeArment


Delivers exclusive investigative journalist content including breaking news and analysis ahead of market-moving events.


Drug Insights:

  • Forward-looking, nuanced, qualitative asset analysis on development, approval & market/reimbursement potential
  • Material intelligence on competitors, including breaking news
  • Insight on companies’ business development needs and strategies

Outsourcing Insights:

Insight on companies’ CRO and business development needs, strategies and relationships


Remove risk and uncertainty

Gain a competitive edge

Secure actionable leads

Premium databases is part of our industry range of products

Subscribe to Company Analytics & gain 12-month access to premium industry data & analytics
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.


Access more premium companies when you subscribe to Explorer